Ask the Expert with Dr. Susan Perlman – January 18th at 1pm.  LEARN MORE


National Ataxia Foundation

NAF Supports FARA’s Call to Action

Friedreich’s Ataxia Research Alliance (FARA) is encouraging Reata Pharmaceuticals to submit a New Drug Application (NDA) for Omaveloxolone, which recently completed a Phase III clinical Read More…

Print Friendly, PDF & Email
Print Friendly, PDF & Email
Translate »